Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 1/8/19941 min de lectura
Conference on Feasibility of Genetic Technology to Close the HIV Window in Donor Screening; Notice of Public Meeting
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA), Office of the Commissioner, is sponsoring a public meeting to evaluate the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative ``window'' phase of human immunodeficiency virus (HIV) infection. DATES: The public meeting will be held on Monday, September 26, 1994, 7 a.m. to 4 p.m. through Wednesday, September 28, l994, 12 m.
Idioma original de la fuente: Federal Register — Health and Human ServicesAbrir el comunicado original →